Literature DB >> 19328787

Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.

Upasna Gaur1, Melissa Showalter, Suzanne Hickerson, Rahul Dalvi, Salvatore J Turco, Mary E Wilson, Stephen M Beverley.   

Abstract

Surface phosophoglycans such as lipophosphoglycan (LPG) or proteophosphoglycan (PPG) and glycosylinositol phospholipids (GIPLs) modulate essential interactions between Leishmania and mammalian macrophages. Phosphoglycan synthesis depends on the Golgi GDP-mannose transporter encoded by LPG2. LPG2-null (lpg2(-)) Leishmania major cannot establish macrophage infections or induce acute pathology, whereas lpg2(-)Leishmania mexicana retain virulence. lpg2(-)Leishmania donovani has been reported to survive poorly in cultured macrophages but in vivo survival has not been explored. Herein we discovered that, similar to lpg2(-)L. major, lpg2(-)L. donovani promastigotes exhibited diminished virulence in mice, but persisted at consistently low levels. lpg2(-)L. donovani promastigotes could not establish infection in macrophages and could not transiently inhibit phagolysosomal fusion. Furthermore, lpg2(-) promastigotes of L. major, L. donovani and L. mexicana were highly susceptible to complement-mediated lysis. We conclude that phosphoglycan assembly and expression mediated by L. donovani LPG2 are important for promastigote and amastigote virulence, unlike L. mexicana but similar to L. major.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328787      PMCID: PMC2720449          DOI: 10.1016/j.exppara.2009.03.014

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  48 in total

Review 1.  Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species.

Authors:  S J Turco; G F Späth; S M Beverley
Journal:  Trends Parasitol       Date:  2001-05

2.  Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes.

Authors:  A Misslitz; J C Mottram; P Overath; T Aebischer
Journal:  Mol Biochem Parasitol       Date:  2000-04-15       Impact factor: 1.759

3.  The role of phosphoglycans in Leishmania-sand fly interactions.

Authors:  D L Sacks; G Modi; E Rowton; G Späth; L Epstein; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.

Authors:  J F Dermine; S Scianimanico; C Privé; A Descoteaux; M Desjardins
Journal:  Cell Microbiol       Date:  2000-04       Impact factor: 3.715

5.  Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

Authors:  G F Späth; L Epstein; B Leader; S M Singer; H A Avila; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 6.  The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness.

Authors:  M A Ferguson; J S Brimacombe; J R Brown; A Crossman; A Dix; R A Field; M L Güther; K G Milne; D K Sharma; T K Smith
Journal:  Biochim Biophys Acta       Date:  1999-10-08

Review 7.  Glycoconjugates in Leishmania infectivity.

Authors:  A Descoteaux; S J Turco
Journal:  Biochim Biophys Acta       Date:  1999-10-08

8.  Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice.

Authors:  T Ilg; M Demar; D Harbecke
Journal:  J Biol Chem       Date:  2000-11-08       Impact factor: 5.157

Review 9.  Proteophosphoglycans of Leishmania.

Authors:  T Ilg
Journal:  Parasitol Today       Date:  2000-11

10.  Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation.

Authors:  T Lang; R Hellio; P M Kaye; J C Antoine
Journal:  J Cell Sci       Date:  1994-08       Impact factor: 5.285

View more
  27 in total

1.  Inhibition of Golgi apparatus glycosylation causes endoplasmic reticulum stress and decreased protein synthesis.

Authors:  Yu-Xin Xu; Li Liu; Carolina E Caffaro; Carlos B Hirschberg
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis.

Authors:  Susan Wyllie; Stephen Patterson; Laste Stojanovski; Frederick R C Simeons; Suzanne Norval; Robert Kime; Kevin D Read; Alan H Fairlamb
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

3.  Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1 Arrest followed by Necrotic Cell Death in Leishmania donovani.

Authors:  Abdul Abduz Zahir; Indira Singh Chauhan; Asokan Bagavan; Chinnaperumal Kamaraj; Gandhi Elango; Jai Shankar; Nidhi Arjaria; Selvaraj Mohana Roopan; Abdul Abdul Rahuman; Neeloo Singh
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infection.

Authors:  Alex Osanya; Eun-Ho Song; Kyle Metz; Raeann M Shimak; Paola Mercedes Boggiatto; Elise Huffman; Charles Johnson; Jesse M Hostetter; Nicola L B Pohl; Christine A Petersen
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 5.  The role of nucleotide sugar transporters in development of eukaryotes.

Authors:  Li Liu; Yu-Xin Xu; Carlos B Hirschberg
Journal:  Semin Cell Dev Biol       Date:  2010-02-06       Impact factor: 7.727

6.  The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence.

Authors:  Bidyottam Mittra; Maria Fernanda Laranjeira-Silva; Danilo Ciccone Miguel; Juliana Perrone Bezerra de Menezes; Norma W Andrews
Journal:  J Biol Chem       Date:  2017-05-26       Impact factor: 5.157

Review 7.  Developmental diseases caused by impaired nucleotide sugar transporters.

Authors:  Li Liu; Carlos B Hirschberg
Journal:  Glycoconj J       Date:  2012-04-17       Impact factor: 2.916

8.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

9.  Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation.

Authors:  Susan Wyllie; Stephen Patterson; Alan H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

10.  Heme uptake mediated by LHR1 is essential for Leishmania amazonensis virulence.

Authors:  Danilo C Miguel; Andrew R Flannery; Bidyottam Mittra; Norma W Andrews
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.